Reprint of "Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits"

Per Hyltoft Petersen, George G. Klee

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Diagnostic decisions based on decision limits according to medical guidelines are different from the majority of clinical decisions due to the strict dichotomization of patients into diseased and non-diseased. Consequently, the influence of analytical performance is more critical than for other diagnostic decisions where much other information is included. The aim of this opinion paper is to investigate consequences of analytical quality and other circumstances for the outcome of "Guideline-Driven Medical Decision Limits". Terms: Effects of analytical bias and imprecision should be investigated separately and analytical quality specifications should be estimated accordingly. Biological variation and analytical performance: Use of sharp decision limits doesn't consider biological variation and effects of this variation are closely connected with the effects of analytical performance. Such relationships are investigated for the guidelines for HbA1c in diagnosis of diabetes and in risk of coronary heart disease based on serum cholesterol. The effects of a second sampling in diagnosis give dramatic reduction in the effects of analytical quality showing minimal influence of imprecision up to 3 to 5% for two independent samplings, whereas the reduction in bias is more moderate and a 2% increase in concentration doubles the percentage of false positive diagnoses, both for HbA1c and cholesterol. Frequency of follow-up laboratory tests: An alternative approach comes from the current application of guidelines for follow-up laboratory tests according to clinical procedure orders, e.g. frequency of parathyroid hormone requests as a function of serum calcium concentrations. Here, the specifications for bias can be evaluated from the functional increase in requests for increasing serum calcium concentrations. Probability function for diagnoses: In consequence of the difficulties with biological variation and the practical utilization of concentration dependence of frequency of follow-up laboratory tests already in use, a kind of probability function for diagnosis as function of the key-analyte is proposed.

Original languageEnglish (US)
Pages (from-to)127-134
Number of pages8
JournalClinica Chimica Acta
Volume432
DOIs
StatePublished - May 15 2014

Fingerprint

Guidelines
Serum
Cholesterol
Sampling
Calcium
Specifications
Medical problems
Parathyroid Hormone
Coronary Disease

Keywords

  • Analytical bias
  • Analytical imprecision
  • Analytical quality specifications
  • Clinical guidelines
  • Clinical outcome
  • Probability function

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical
  • Medicine(all)

Cite this

Reprint of "Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits". / Hyltoft Petersen, Per; Klee, George G.

In: Clinica Chimica Acta, Vol. 432, 15.05.2014, p. 127-134.

Research output: Contribution to journalArticle

@article{fe96d7deaca44bd0948f853d3f419af2,
title = "Reprint of {"}Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits{"}",
abstract = "Background: Diagnostic decisions based on decision limits according to medical guidelines are different from the majority of clinical decisions due to the strict dichotomization of patients into diseased and non-diseased. Consequently, the influence of analytical performance is more critical than for other diagnostic decisions where much other information is included. The aim of this opinion paper is to investigate consequences of analytical quality and other circumstances for the outcome of {"}Guideline-Driven Medical Decision Limits{"}. Terms: Effects of analytical bias and imprecision should be investigated separately and analytical quality specifications should be estimated accordingly. Biological variation and analytical performance: Use of sharp decision limits doesn't consider biological variation and effects of this variation are closely connected with the effects of analytical performance. Such relationships are investigated for the guidelines for HbA1c in diagnosis of diabetes and in risk of coronary heart disease based on serum cholesterol. The effects of a second sampling in diagnosis give dramatic reduction in the effects of analytical quality showing minimal influence of imprecision up to 3 to 5{\%} for two independent samplings, whereas the reduction in bias is more moderate and a 2{\%} increase in concentration doubles the percentage of false positive diagnoses, both for HbA1c and cholesterol. Frequency of follow-up laboratory tests: An alternative approach comes from the current application of guidelines for follow-up laboratory tests according to clinical procedure orders, e.g. frequency of parathyroid hormone requests as a function of serum calcium concentrations. Here, the specifications for bias can be evaluated from the functional increase in requests for increasing serum calcium concentrations. Probability function for diagnoses: In consequence of the difficulties with biological variation and the practical utilization of concentration dependence of frequency of follow-up laboratory tests already in use, a kind of probability function for diagnosis as function of the key-analyte is proposed.",
keywords = "Analytical bias, Analytical imprecision, Analytical quality specifications, Clinical guidelines, Clinical outcome, Probability function",
author = "{Hyltoft Petersen}, Per and Klee, {George G.}",
year = "2014",
month = "5",
day = "15",
doi = "10.1016/j.cca.2014.04.002",
language = "English (US)",
volume = "432",
pages = "127--134",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - Reprint of "Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits"

AU - Hyltoft Petersen, Per

AU - Klee, George G.

PY - 2014/5/15

Y1 - 2014/5/15

N2 - Background: Diagnostic decisions based on decision limits according to medical guidelines are different from the majority of clinical decisions due to the strict dichotomization of patients into diseased and non-diseased. Consequently, the influence of analytical performance is more critical than for other diagnostic decisions where much other information is included. The aim of this opinion paper is to investigate consequences of analytical quality and other circumstances for the outcome of "Guideline-Driven Medical Decision Limits". Terms: Effects of analytical bias and imprecision should be investigated separately and analytical quality specifications should be estimated accordingly. Biological variation and analytical performance: Use of sharp decision limits doesn't consider biological variation and effects of this variation are closely connected with the effects of analytical performance. Such relationships are investigated for the guidelines for HbA1c in diagnosis of diabetes and in risk of coronary heart disease based on serum cholesterol. The effects of a second sampling in diagnosis give dramatic reduction in the effects of analytical quality showing minimal influence of imprecision up to 3 to 5% for two independent samplings, whereas the reduction in bias is more moderate and a 2% increase in concentration doubles the percentage of false positive diagnoses, both for HbA1c and cholesterol. Frequency of follow-up laboratory tests: An alternative approach comes from the current application of guidelines for follow-up laboratory tests according to clinical procedure orders, e.g. frequency of parathyroid hormone requests as a function of serum calcium concentrations. Here, the specifications for bias can be evaluated from the functional increase in requests for increasing serum calcium concentrations. Probability function for diagnoses: In consequence of the difficulties with biological variation and the practical utilization of concentration dependence of frequency of follow-up laboratory tests already in use, a kind of probability function for diagnosis as function of the key-analyte is proposed.

AB - Background: Diagnostic decisions based on decision limits according to medical guidelines are different from the majority of clinical decisions due to the strict dichotomization of patients into diseased and non-diseased. Consequently, the influence of analytical performance is more critical than for other diagnostic decisions where much other information is included. The aim of this opinion paper is to investigate consequences of analytical quality and other circumstances for the outcome of "Guideline-Driven Medical Decision Limits". Terms: Effects of analytical bias and imprecision should be investigated separately and analytical quality specifications should be estimated accordingly. Biological variation and analytical performance: Use of sharp decision limits doesn't consider biological variation and effects of this variation are closely connected with the effects of analytical performance. Such relationships are investigated for the guidelines for HbA1c in diagnosis of diabetes and in risk of coronary heart disease based on serum cholesterol. The effects of a second sampling in diagnosis give dramatic reduction in the effects of analytical quality showing minimal influence of imprecision up to 3 to 5% for two independent samplings, whereas the reduction in bias is more moderate and a 2% increase in concentration doubles the percentage of false positive diagnoses, both for HbA1c and cholesterol. Frequency of follow-up laboratory tests: An alternative approach comes from the current application of guidelines for follow-up laboratory tests according to clinical procedure orders, e.g. frequency of parathyroid hormone requests as a function of serum calcium concentrations. Here, the specifications for bias can be evaluated from the functional increase in requests for increasing serum calcium concentrations. Probability function for diagnoses: In consequence of the difficulties with biological variation and the practical utilization of concentration dependence of frequency of follow-up laboratory tests already in use, a kind of probability function for diagnosis as function of the key-analyte is proposed.

KW - Analytical bias

KW - Analytical imprecision

KW - Analytical quality specifications

KW - Clinical guidelines

KW - Clinical outcome

KW - Probability function

UR - http://www.scopus.com/inward/record.url?scp=84901586514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901586514&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2014.04.002

DO - 10.1016/j.cca.2014.04.002

M3 - Article

C2 - 24747109

AN - SCOPUS:84901586514

VL - 432

SP - 127

EP - 134

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -